Disseminated Enteroviral Infection Associated with Obinutuzumab

Research output: Contribution to journalArticleOther

9 Citations (Scopus)

Abstract

Two cases of disseminated enteroviral infection occurred in patients who received the CD20 monoclonal antibody obinutuzumab. Clinical features included hepatitis, edema, and a dermatomyositis-like syndrome. These manifestations may be unfamiliar to clinicians and are possibly responsive to intravenous immunoglobulin. Clinicians should remain vigilant for enteroviral infections in patients receiving obinutuzumab.
Original languageEnglish
Pages (from-to)1661 - 1663
Number of pages3
JournalEmerging Infectious Diseases
Volume21
Issue number9
DOIs
Publication statusPublished - 2015

Cite this